ArticleFrontiers in pharmacology2020

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma.

Zhenzhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.